Large Multinational Pharma
Bringing content and compliance together in the world of healthcare marketing.
A large multinational pharma company has spent nearly a century driving change to defeat serious chronic diseases. With that kind of legacy, their digital content operations needed to match their pace of innovation.
They had the right tools: Adobe Experience Manager for content authoring, Workfront for content orchestration, and Veeva Vault PromoMats for MLR review and digital asset management. But their ecosystem was fragmented. Content teams in different channels were recreating assets instead of reusing them. MLR submissions and corrections were taking weeks. Speed to market suffered.
For a company bringing life-changing treatments to patients, every day matters.
Connecting platforms, accelerating impact
We helped a large multinational pharma company solve a highly visible, operational challenge by connecting their content lifecycle from authoring to approval.
Their ecosystem of systems, their teams, and their content had become disconnected. We used our integration expertise and ingenuity to bring the systems that support enterprise healthcare digital content together seamlessly.
The solution created a single source of truth for content that allowed teams to work with more confidence, create content faster, and deliver stronger healthcare experiences across channels.
Integrated AEM authoring directly with Veeva MLR review processes, eliminating manual handoffs.
Built automated MLR submission workflows that maintain regulatory compliance while accelerating approvals.
Established a "create once, publish everywhere" content strategy with modular asset architecture.
Developed comprehensive training programs and ongoing platform support for all user groups.
Cut MLR submission time by more than 70%
From fragmented to fluid
The value achieved through our XpConnect® platform integration has been significant across multiple dimensions. While speed to market was the primary focus, Novo Nordisk is seeing notable increases in MLR submission quality alongside meaningful cost reductions.
The improvements are immediate and measurable, but the real win is systematic: Novo Nordisk now has a content operation that scales with their ambitions. As they develop new treatments and enter new markets, their content infrastructure adapts automatically.
With ongoing innovation partnership in place, they're positioned for continued improvements in both speed to market and operational efficiency.
It’s the multiplier effect
When content operations work seamlessly, everything else accelerates. Marketing teams focus on strategy instead of asset hunting. Compliance reviews happen in real-time, not in queues. Brand teams can respond to market opportunities without waiting for content creation cycles.
For Novo Nordisk, integrated content operations mean their breakthrough science reaches patients faster. In healthcare, that difference is measured in lives, not just metrics.
The platform we built together positions them for continued innovation, with content operations that will scale alongside their next century of medical breakthroughs.
